About Us

The mission of Minnesota Medical Technologies is to develop, make, and sell continence care products of unmatched performance, comfort, and quality throughout the world. We’re headquartered in Stewartville, MN, which is right outside America’s “Med City,” Rochester. Our history of innovation and quality in healthcare is a point of pride.

Our team has been in this business for a long time: we’ve worked with silicone technology for more than 30 years and have invented, developed, and brought to market many successful continence care products. These products have improved the lives of millions of people around the world. Now Minnesota Medical Technologies is home to the next innovation in continence care, myMiracle®, a unique device for fecal incontinence management.

Our work is grounded in a genuine understanding of what individuals face when they deal with fecal incontinence. Staying at home often. Traveling with spare clothing and careful planning. The sheer uncertainty of everyday life. We believe the FI products on the market just aren’t good enough to bring your day back under control. Many times they fail to effectively prevent accidental bowel leakage, odours, or are difficult to use.

We knew there had to be a better solution. We asked ourselves, what would it take for someone with FI to feel confident again? To feel ready, willing, eager to get out and live their life? We talked with people who carry on with FI every day. It seemed it would take a miracle to get that confidence back, that simple feeling of freedom that we never notice until it’s taken from us. So that’s what we set out to accomplish: a miracle. With our accomplished team of doctors, engineers, and researchers, myMiracle® became possible. Now we’re ready to bring it to you.

myMiracle® has the potential to change lives across the world. Contact Minnesota Medical Technologies today for more information about myMiracle®.

Our Team

At Minnesota Medical Technologies, the Founders and Team Members offer a long and storied history of innovation. Whether conceptualizing and developing new product ideas and technologies to address customer needs, or designing and building our own highly specialized, high-volume production systems, creativity and innovation are always at the forefront of our efforts.

Current products and treatment methods are oftentimes inadequate and do not address the negative impact on a person’s quality of life or risk of infection. Minnesota Medical Technologies is dedicated to providing elegant solutions that provide comfort and protection to those who need it. Our aim is to help those who deal with fecal incontinence to regain dignity and control with our advanced technology solutions.

Mr. Jonas serves as CEO and President. He was Minnesota Medical’s CFO from 2017-2018. From 1998 to 2013 Mr. Jonas held various positions at Rochester Medical Corp. including Controller, Director of Operations and CFO; he also served on the Board of Directors. Prior to joining Rochester Medical Corp., Mr. Jonas held various financial, financial management and operational positions at Polaris Industries, Inc.

Mr. Conway is responsible for plant design as well as new product and production processes, research, design, and development activities. From 2013 to 2015, Mr. Conway served as VP Production Technologies of BCG Technologies. From 1988 to 2013, Mr. Conway was VP Operations at Rochester Medical Corp. for which he was also a Founder. From 1979 to 1988, he was VP Production and a founder of Arcon Corp.

Ms. Grinde is responsible for invention and development of new technologies, project management/product development, and business activities related to the strategic deployment and introduction of new technologies and products on a global basis. From 2013 to 2015, Ms. Grinde was VP Research & Development for BCG Technologies. From 2006 to 2013, Ms. Grinde served in Marketing and was VP Research & Development at Rochester Medical Corp.

Mr. Anglin is responsible for all Quality and Regulatory affairs including Quality System design and implementation and FDA and regulatory matters. From 2013 to 2016, Mr. Anglin served as VP Quality BMD, Homecare at CR Bard. From 1991 to 2013, Mr. Anglin served as VP Quality & Regulatory at Rochester Medical Corporation. Mr. Anglin has medical device experience in the areas of product development, quality systems, regulatory affairs, and manufacturing operations. He has experience with Class I, II, and III medical devices and drug/device combination products within the areas of urinary and fecal incontinence.

Mr. Sholtis is responsible for worldwide business development activities. From 1992 to 2013, Mr. Sholtis held various positions at Rochester Medical Corp. in Sales, Marketing, and Business Development; most recently as Corporate Vice President. Prior to joining Rochester Medical Corp., Mr. Sholtis worked for Sherwood Medical in Sales and Sales Management.

Mr. Conway also actively contributes to research, development and design activities. From 2013 to 2018, Mr. Conway served as President of BCG Technologies and Minnesota Medical. From 1988 to 2013, Mr. Conway was CEO and President at Rochester Medical Corp. for which he was also a Founder. From 1979 to 1988, he was President of Arcon Corp., a company that he co-founded with Philip J Conway. Prior to founding Arcon, Mr. Conway worked for 12 years for International Business Machines Corp. in various research and development capacities.

Ms. Boe coordinates executive activities and schedules, and serves as Manager of the Facilities. From 2013 to 2015, Ms. Boe served in the same capacity at BCG Technologies. From 1997 to 2013, Ms. Boe served as Executive Secretary to Anthony J. Conway.

Mr. Couture is responsible for executing the commercial sales strategy in multiple markets served by our innovative solutions. From 2013 to 2023, Mr. Couture was national Sales Director at C.R. Bard/Becton Dickinson where he led both the outside and inside sales team along with a clinical nurse manager team. From 2002 to 2013, Mr. Couture held a number of sales leadership roles at Rochester Medical Corp.